Blogposts über unsere Produkte, Kooperationen, Neuheiten,…
Effectiveness of using the REAtouch® during intensive and functional HABIT-ILE intervention for children with unilateral cerebral palsy
We are pleased to announce the publication of a randomised controlled trial evaluating the effectiveness of an intensive and functional HABIT-ILE (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities)
First clinical evaluation of the REAtouch® Home, for a personalised, functional and long-term neurorehabilitation at home.
The team of Professor Thierry LEJEUNE, medical practitioner from the physical medicine and rehabilitation department of the Cliniques universitaires Saint-Luc, has started the first clinical evaluation of the REAtouch® Home
Der REAplan® 3.4 – Ein neues Design mit verbesserter Zugänglichkeit
Anfang 2023 bringt Axinesis die neue Version des Endeffektor-Roboters auf den Markt. Den REAplan® 3.4 Eine verbesserte Benutzerfreundlichkeit und einfachere Anpassungsfähigkeit zeichnen die neue Version 3.4 aus. Dank des Feedbacks der
New Chief Medical Officer (CMO) started at Axinesis from the 1st of September !
Since the 1st of September, a new member has joined Axinesis. Maxime Gilliaux, physiotherapist, doctor in motor sciences and Executive MBA in health, is now our Chief Medical Officer. He
Proven effectiveness of early Robotic Assisted Therapy for upper limb rehabilitation after stroke
Study provides further evidence for the effectiveness of robot-assisted therapy in stroke upper limb rehabilitation Robot-assisted therapy (RAT) is of significant interest in early rehabilitation, when neuroplasticity is high but
Die Ankunft des REAtouch Lite® bei Axinesis
Axinesis erweitert sein Angebot an intensiver funktioneller Rehabilitation Wir freuen uns, die Einführung unseres neuen REAtouch® Lite ankündigen zu können: das Gerät für die dezentrale Rehabilitation der oberen Gliedmaßen im